All Stories

  1. In vitro activity of cefiderocol against nosocomial Acinetobacter baumannii
  2. Virulence and Resistance of Pseudomonas aeruginosa Isolated from Poultry in Brazil
  3. Highly clonal carbapenem-resistant Acinetobacter baumannii isolates from a Peruvian hospital
  4. Escherichia coli Sequence Type 131-H22 in Parrots from Illegal Pet Trade, Brazil, 2024
  5. In vitro activity of cefiderocol against ESBL-producing and carbapenem-resistant Pseudomonas aeruginosa
  6. Detection of rare β-lactamase blaSCO-1 from a Klebsiella pneumoniae high-risk clone in Peru
  7. Carbapenem-Resistant Pseudomonas aeruginosa from Guanay Cormorants on Is. Pescadores, Peru
  8. Comparación de la carga bacteriana de Escherichia coli enteroagregativa (EAEC) mediante un PCR en tiempo real (qPCR) en niños con diarrea e infección asintomática
  9. 10 millones de muertes anuales, y no es noticia
  10. Direct economic costs related to antimicrobial resistance in bloodstream infections isolated from newborns in a perinatal hospital in Peru
  11. Antibiotic-Resistant Pseudomonas aeruginosa from Market Meat in Peru
  12. Antimicrobial resistance and associated risk factors in Escherichia coli isolated from Peruvian dogs: A focus on extended-spectrum β-lactamases and colistin
  13. Unusual and Unconsidered Mechanisms of Bacterial Resilience and Resistance to Quinolones
  14. Molecular characterization of carbapenemase-producing Enterobacterales in a tertiary hospital in Lima, Peru
  15. Determinación e interpretación de la sensibilidad a cefiderocol
  16. Resistencia a antimicrobianos: Causas
  17. South Health, una nueva revista científica Peruana
  18. Message or messenger, that's the right question
  19. Single-nucleotide polymorphisms in ialB, gltA and rpoB genes of Bartonella bacilliformis isolated from patients in endemic Peruvian regions
  20. Super-infection by multiple microorganisms in COVID-19 patients
  21. Class 1 and 2 Integrons in Escherichia coli Strains Isolated from Diarrhea and Bacteremia in Children Less Than 2 Years of Age from Peru
  22. First report of CrpP prevalence in a South American country
  23. Phenotypic Characteristics and Clonal Relationships of Stenotrophomonas maltophilia Isolates in Hospitalized Adults from a Private Center in Lima, Peru
  24. JMM Profile: Bartonella bacilliformis: a forgotten killer
  25. High rates of extensively drug-resistant Acinetobacter baumannii in a Peruvian hospital 2013–2019
  26. KPC-2-NDM-1-producing Serratia marcescens: first description in Peru
  27. Evolution of the prevalence and antimicrobial resistance among Escherichia coli isolated as a cause of infection in patients admitted to a iv-level hospital in Lima, Peru
  28. Antibiotic susceptibility among non-clinical Escherichia coli as a marker of antibiotic pressure in Peru (2009–2019): one health approach
  29. Recurrence of Urinary Tract Infections due to Escherichia coli and Its Association with Antimicrobial Resistance
  30. COVID-19: chronicle of a pandemic foretold
  31. Worrying levels of antimicrobial resistance in Gram-negative bacteria isolated from cell phones and uniforms of Peruvian intensive care unit workers
  32. High Prevalence of blaCTX-M in Fecal Commensal Escherichia coli from Healthy Children
  33. Retrospective analysis of the emergence of antibiotic-resistant Salmonella enterica infections in a level IV hospital from Lima, Peru
  34. Antimicrobial Resistance, from bench-to-publicside
  35. Immunogenic Peptides from Pap31 and SCS-α of Bartonella bacilliformis: One Step Closer to a Rapid Diagnostic Tool for Carrion’s Disease
  36. Molecular Characterization of Fluoroquinolone-Resistant Bartonella bacilliformis
  37. Type 3 secretion system as an anti-Pseudomonal target
  38. Type 3 secretion system of Pseudomonas aeruginosa
  39. Caracterización de Escherichia coli D7111 productora de β-lactamasa TEM-176
  40. Frecuencia de genes que codifican proteínas autotransportadoras serinproteasa de Enterobacteriaceae (SPATE) en cepas de Escherichia coli difusamente adherente (DAEC) provenientes de niños con y sin diarrea
  41. Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital
  42. Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect?
  43. Research inequities: avoiding the next pandemic
  44. Escherichia coli ST131 clones harbouring AggR and AAF/V fimbriae causing bacteremia in Mozambican children: Emergence of new variant of fimH27 subclone
  45. Resistencia a nitrofuranos mediada por mutaciones en los genes cnr y snrA en Salmonella enterica procedentes de muestras cárnicas para consumo humano
  46. Transferable Mechanisms of Quinolone Resistance from 1998 Onward
  47. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals
  48. CrpP, a passenger or a hidden stowaway in the Pseudomonas aeruginosa genome?
  49. Presence of Extended-Spectrum β-lactamase, CTX-M-65 in Salmonella enterica serovar Infantis Isolated from Children with Diarrhea in Lima, Peru
  50. Azithromycin resistance levels and mechanisms in Escherichia coli
  51. Reflexión acerca del concepto de “Una salud”
  52. Specific type IV pili groups in clinical isolates of Pseudomonas aeruginosa
  53. Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
  54. Bartonella quintana , past, present, and future of the scourge of World War I
  55. Revisiting Bartonella bacilliformis MLST
  56. Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum β-lactamases causing bacteremia and urinary tract infection in Manhiça, M...
  57. Differences in tetracycline resistance determinant carriage among Shigella flexneri and Shigella sonnei are not related to different plasmid Inc-type carriage
  58. Analysis of the presence of erroneous Qnr sequences in GenBank
  59. Salmonella enterica serovars Typhimurium and Enteritidis causing mixed infections in febrile children in Mozambique
  60. Resistance to quinolones, cephalosporins and macrolides in Escherichia coli causing bacteraemia in Peruvian children
  61. Carrion's Disease: the Sound of Silence
  62. Molecular and Phenotypic Characterization of Diarrheagenic Escherichia coli Strains Isolated from Bacteremic Children
  63. Immunosuppressive and angiogenic cytokine profile associated with Bartonella bacilliformis infection in post-outbreak and endemic areas of Carrion's disease in Peru
  64. Characterisation of the first KPC-2-producing Klebsiella pneumoniae ST340 from Peru
  65. Virulence and Antimicrobial Resistance inCampylobacterspp. from a Peruvian Pediatric Cohort
  66. Antimicrobial resistance levels among diarrhoeagenic micro-organisms recovered from children under-5 with acute moderate-to-severe diarrhoea in Rabat, Morocco
  67. Carrion’s disease: an eradicable illness?
  68. Macrolide resistance mechanisms inEnterobacteriaceae: Focus on azithromycin
  69. Carrion’s Disease: More Than a Sand Fly–Vectored Illness
  70. Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants
  71. Succinyl-CoA Synthetase: New Antigen Candidate of Bartonella bacilliformis
  72. Virulence factors profiles and ESBL production in Escherichia coli causing bacteremia in Peruvian children
  73. Whole-Genome Sequencing of Two Bartonella bacilliformis Strains
  74. picgene of enteroaggregativeEscherichia coliand its association with diarrhea in Peruvian children
  75. Pathogenicity Island O-122 in enteropathogenic Escherichia coli strains is associated with diarrhea severity in children from Lima Peru
  76. Prevalencia de compra sin receta y recomendación de antibióticos para niños menores de 5 años en farmacias privadas de zonas periurbanas en Lima, Perú
  77. Evaluation of PCR Approaches for Detection of Bartonella bacilliformis in Blood Samples
  78. Multi-Locus Sequence Typing of Bartonella bacilliformis DNA Performed Directly from Blood of Patients with Oroya’s Fever During a Peruvian Outbreak
  79. Bordetella pertussis diagnosis in children under five years of age in the Regional Hospital of Cajamarca, Northern Peru
  80. InvasiveSalmonellaInfections Among Children From Rural Mozambique, 2001–2014
  81. Antibiotic resistance in Bartonella bacilliformis clinical isolates from an endemic area of Peru
  82. Proteins of Bartonella bacilliformis: Candidates for Vaccine Development
  83. Comparative analysis of antimicrobial resistance in enterotoxigenicEscherichia coliisolates from two paediatric cohort studies in Lima, Peru
  84. A comparison of human metapneumovirus and respiratory syncytial virus WHO-defined severe pneumonia in Moroccan children
  85. Characterization of two Achromobacter xylosoxidans isolates from patients with pertussis-like symptoms
  86. Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru)
  87. Development and analysis of furazolidone‐resistant Escherichia coli mutants
  88. An unidentified cluster of infection in the Peruvian Amazon region
  89. Diarrheal Disease in Rural Mozambique: Burden, Risk Factors and Etiology of Diarrheal Disease among Children Aged 0–59 Months Seeking Care at Health Facilities
  90. Characterisation of extended-spectrum β-lactamases among Klebsiella pneumoniae isolates causing bacteraemia and urinary tract infection in Mozambique
  91. Possible Vertical Transmission of Bartonella bacilliformis in Peru
  92. Aetiology, epidemiology and clinical characteristics of acute moderate-to-severe diarrhoea in children under 5 years of age hospitalized in a referral paediatric hospital in Rabat, Morocco
  93. Diarrheagenic Escherichia coli Phylogroups Are Associated with Antibiotic Resistance and Duration of Diarrheal Episode
  94. Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco
  95. Feeding of Young Children During Diarrhea: Caregivers' Intended Practices and Perceptions
  96. Identification of human papillomavirus as a preventive strategy for cervical cancer in asymptomatic women in the Peruvian Andes
  97. Diarrhoea caused by rotavirus in a regional Peruvian hospital: determination of circulating genotypes
  98. Diagnosis of Carrion’s Disease by Direct Blood PCR in Thin Blood Smear Negative Samples
  99. The Epidemiology and Aetiology of Infections in Children Admitted with Clinical Severe Pneumonia to a University Hospital in Rabat, Morocco
  100. Development of a 16S rRNA PCR-RFLP Assay for Bartonella identification: Applicability in the Identification of Species Involved in Human Infections
  101. Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru
  102. Prevention of travellers' diarrhoea: where and who?
  103. Detection of Secretory Immunoglobulin A in Human Colostrum as Mucosal Immune Response Against Proteins of the Type III Secretion System of Salmonella, Shigella and Enteropathogenic Escherichia Coli
  104. Which mechanisms of azithromycin resistance are selected when efflux pumps are inhibited?
  105. Antibiotic Usage Prior and During Hospitalization for Clinical Severe Pneumonia in Children under Five Years of Age in Rabat, Morocco
  106. Antimicrobial resistance in Shigella spp. causing traveller's diarrhoea (1995–2010): A retrospective analysis
  107. Relevant role of efflux pumps in high levels of rifaximin resistance in Escherichia coli clinical isolates
  108. Multiplex Real-Time PCR for Detection of Campylobacter, Salmonella, and Shigella
  109. Factors Affecting Caregivers’ Use of Antibiotics Available Without a Prescription in Peru
  110. In Vitro Development and Analysis of Escherichia coli and Shigella boydii Azithromycin–Resistant Mutants
  111. QnrVC, a new transferable Qnr-like family
  112. β-Lactamases, transferable quinolone resistance determinants, and class 1 integron-mediated antimicrobial resistance in human clinical Salmonella enterica isolates of non-Typhimurium serotypes
  113. Genotypic Characterization of Enterotoxigenic Escherichia coli Strains Causing Traveler's Diarrhea
  114. Molecular mechanisms of antibiotic resistance in diarrhoeagenic Escherichia coli isolated from children
  115. Transferable mechanisms of quinolone resistance
  116. Fitness and Molecular Mechanisms of Resistance to Rifaximin in In Vitro Selected Escherichia coli Mutants
  117. Genetic diversity of locus of enterocyte effacement genes of enteropathogenic Escherichia coli isolated from Peruvian children
  118. Intrahospitalary dissemination of Klebsiella pneumoniae carrying blaDHA-1 and qnrB4 genes within a novel complex class 1 integron
  119. Plasmid-mediated quinolone resistance genes in enteroaggregative Escherichia coli from infants in Lima, Peru
  120. Effect of bovine lactoferrin on the minimum inhibitory concentrations of ampicillin and trimethoprim–sulfamethoxazole for clinical Shigella spp. strains1This article is part of a Special Issue entitled Lactoferrin and has undergone th...
  121. Use of Commercially Available Oral Rehydration Solutions in Lima, Peru
  122. Niveles de resistencia a quinolonas y otros antimicrobianos en cepas de Escherichia coli comensales en niños de la zona periurbana de Lima, Perú
  123. Short communication: Detection of Shiga toxin-producing Escherichia coli (STEC) in healthy cattle and pigs in Lima, Peru
  124. Norovirus prevalence in ‘pathogen negative’ gastroenteritis in children from periurban areas in Lima, Peru
  125. Quantitative Real-time Polymerase Chain Reaction for Enteropathogenic Escherichia coli: A Tool for Investigation of Asymptomatic Versus Symptomatic Infections
  126. Molecular Surveillance of Circulating Dengue Genotypes Through European Travelers
  127. Molecular epidemiology and resistance mechanisms involved in reduced susceptibility to amoxicillin/clavulanic acid in Klebsiella pneumoniae isolates from a chronic care centre
  128. Phylogenetic relationships of Shiga toxin-producing Escherichia coli isolated from Peruvian children
  129. Frecuencia y patotipos de Escherichia coli diarrogénicas en niños peruanos con y sin diarrea
  130. Antimicrobial Drug Resistance Trends of Bacteremia Isolates in a Rural Hospital in Southern Mozambique
  131. Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones
  132. Genetic analysis by pulsed-field gel electrophoresis of Enteropathogenic Escherichia coli (EPEC) strains isolated from Peruvian children
  133. Role of Efflux pumps in the development of quinolone-resistance in Peruvian Escherichia coli isolates
  134. Characterization of the enzyme aac(3)-id in a clinical isolate of Salmonella enterica serovar Haifa causing traveler's diarrhea
  135. Multidrug resistance related to class 1 integrons in human Salmonella enterica serotype Typhimurium isolates and emergence of atypical sul3-associated integrons
  136. Invasive non-typhoidal Salmonella in Mozambican children
  137. Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers
  138. Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea
  139. Antimicrobial Susceptibility and Mechanisms of Resistance in Shigella and Salmonella Isolates from Children under Five Years of Age with Diarrhea in Rural Mozambique
  140. Estudio clinicoepidemiológico del dengue importado en España
  141. Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability
  142. Quinolone resistance among Shigella spp. isolated from travellers returning from India
  143. In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea
  144. Molecular typing of Staphylococcus aureus clinical isolates by pulsed-field gel electrophoresis, staphylococcal cassette chromosome mec type determination and dissemination of antibiotic resistance genes
  145. Epidemiology and Clinical Presentation of Shigellosis in Children Less Than Five Years of Age in Rural Mozambique
  146. Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhiça District Hospital, southern Mozambique
  147. Salmonella ovarian abscess following travel diarrhoea episode
  148. Resistance to quinolones in Salmonella infantis due to overexpression of an active efflux system and a mutation in the gyrA gene
  149. Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea
  150. Molecular Epidemiology of Macrolide and Tetracycline Resistances in Commensal Gemella sp. Isolates
  151. Class 1 Integrons in Salmonella Strains Causing Traveler's Diarrhea
  152. Outbreak of Infection WithAcinetobacterStrain RUH 1139 in an Intensive Care Unit
  153. Evidence for a reserpine‐affected mechanism of resistance to tetracycline in Neisseria gonorrhoeae
  154. Ciprofloxacin, Salicylate, and 2,4-Dinitrophenol Decrease Production of AmpC-Type β-Lactamase in Two Citrobacter freundii Clinical Isolates
  155. Validación de la técnica de PCR para la detección de Escherichia coli enteroagregativa causante de diarrea del viajero
  156. A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates
  157. Prevalence of Pathogenicity Island IICFT073 Genes among Extraintestinal Clinical Isolates of Escherichia coli
  158. Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa
  159. Mechanism of Resistance to Several Antimicrobial Agents in Salmonella Clinical Isolates Causing Traveler's Diarrhea
  160. Mechanisms of Resistance in Multiple-Antibiotic-Resistant Escherichia coli Strains of Human, Animal, and Food Origins
  161. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates
  162. Mecanismos de resistencia a betalactámicos y ácido nalidíxico en aislados clínicos de Salmonella enterica serotipo hadar y bsilla
  163. Antibiotic resistance and epidemiological typing of Staphylococcus aureus strains from ovine and rabbit mastitis
  164. Molecular characterization of the integrons in S higella strains isolated from patients with traveler's diarrhea
  165. Effect of the efflux pump inhibitor Phe-Arg- -naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin
  166. Mecanismos de resistencia a betalactámicos y ácido nalidíxico en aislados clínicos de Salmonella enterica serotipo hadar y bsilla
  167. In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance
  168. Blood Cultures for Women with Uncomplicated Acute Pyelonephritis: Are They Necessary?
  169. Dispersión intercontinental de una cepa de Shigella flexneri resistente a trimetoprima
  170. Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain
  171. Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii
  172. Detection of dihydrofolate reductase genes by PCR and RFLP
  173. Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii
  174. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene
  175. Analysis of the clonal relationship among clinical isolates of Salmonella enterica serovar Infantis by different typing methods
  176. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection
  177. Clonal Dissemination of Yersinia enterocolitica Strains with Various Susceptibilities to Nalidixic Acid
  178. Dispersión intercontinental de una cepa de Shigella flexneri resistente a trimetoprima
  179. Differences in Virulence Factors among Clinical Isolates of Escherichia coli Causing Cystitis and Pyelonephritis in Women and Prostatitis in Men
  180. Characterization of an Integron Carrying a New Class D β -Lactamase (OXA-37) in Acinetobacter baumannii
  181. Mutations in gyrA and parC QRDRs Are Not Relevant for Quinolone Resistance in Epidemiological Unrelated Stenotrophomonas maltophilia Clinical Isolates
  182. Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus
  183. Are Quinolone‐Resistant UropathogenicEscherichia coliLess Virulent?
  184. Distribution of beta-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different beta-lactam antibiotics
  185. Prevalence of the sat Gene among Clinical Isolates of Shigella spp. Causing Travelers' Diarrhea: Geographical and Specific Differences
  186. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae
  187. Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates
  188. Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates
  189. In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine
  190. Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis
  191. Decreased Invasive Capacity of Quinolone‐Resistant Escherichia coli in Patients with Urinary Tract Infections
  192. Susceptibility patterns of enteroaggregative Escherichia coli associated with traveller's diarrhoea: emergence of quinolone resistance
  193. Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones
  194. Characterization of sparfloxacin-resistant mutants of Staphylococcus aureus obtained in vitro
  195. In vitro activity of rifaximin against bacterial enteropathogens causing diarrhoea in children under 5 years of age in Ifakara, Tanzania
  196. In Vitro Activity of Rifaximin against Enteropathogens Producing Traveler's Diarrhea
  197. Prevalence of two different genes encoding NorA in 23 clinical strains of Staphylococcus aureus
  198. Quinolone Resistance in EnterotoxigenicEscherichia coli Causing Diarrhea in Travelers to India in Comparison with Other Geographical Areas
  199. In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition
  200. Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii
  201. Resolution of high-molecular-weight components in lipopolysaccharides of Escherichia coli, Morganella morganii, Citrobacter freundii and Citrobacter diversus strains with sodium dodecyl sulfate polyacrylamide gels
  202. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii
  203. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates
  204. Mechanisms of resistance to ampicillin, chloramphenicol and quinolones in multiresistant Salmonella typhimurium strains isolated from fish
  205. Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance
  206. Decreased Production of AmpC-Type β-Lactamases Associated with the Development of Resistance to Quinolones inCitrobacter freundiiStrains
  207. Campylobacter jejuni as a Cause of Traveler's Diarrhea: Clinical Features and Antimicrobial Susceptibility
  208. Increased Resistance to Quinolones in Campylobacter jejuni: A Genetic Analysis of gyrA Gene Mutations in Quinolone‐Resistant Clinical Isolates
  209. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium
  210. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
  211. The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates
  212. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii
  213. High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coti
  214. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs.